Li, Amber Xinyu, Martin, Tracey A. ![]() ![]() ![]() ![]() |
Preview |
PDF
- Published Version
Available under License Creative Commons Attribution. Download (1MB) | Preview |
Abstract
The STRIPAK (striatin-interacting phosphatase and kinase) complex and its central components, striatins (STRNs), have attracted significant interest with regard to the pathological development of diseases over the last decade, particular in the area of cancer research. Beyond their roles in regulating several oncogenic signalling cascades, the clinical relevance of the STRIPAK constituents has intensified research attention towards this supramolecular assembly. However, the complex nature of the complex poses research challenges, and our current understanding provides only a partial view of its functions. As a complex of phosphatases and kinases, its diverse signalling partners further complicate the precise determination of its roles within cancer development. Hence, further research is necessary to unveil and establish its significance as an emerging biomarker. This review consolidates the existing cellular and biological knowledge of STRNs and the STRIPAK members, while also highlighting their demonstrated clinical significance across various cancer types. The current research challenges and future perspectives are also discussed.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Publisher: | MDPI |
ISSN: | 2072-6694 |
Funders: | NA |
Date of First Compliant Deposit: | 22 December 2023 |
Date of Acceptance: | 20 December 2023 |
Last Modified: | 12 Jan 2024 10:45 |
URI: | https://orca.cardiff.ac.uk/id/eprint/165043 |
Actions (repository staff only)
![]() |
Edit Item |